2WHO Expert Committee on Leprosy.Seventh Report[R].WHO Tech Rep,1998,874:1-43.
3FiageulB.Current guidelines for leprosy treatment[J].Bull Soc Pathol Exot,2003,96(5):357-361.
4Ali MK,Thorat DM,Subramanian M,et al..A study on trend of relapse in leprosy and factors influencing relapse[J].Indian J Lepr,2005,77(2):105-115.
5Williams DL,Spring L,Harris E,et al..Dihydropteroate synthase of Mycobacterium Leprae and dapsone resistance[J].Antimicrobiol Agents &Chemotherpy,2000,44(6):1530-1537.
6Lee SB,Chun JH,Kim NH,et al..The prevalence of folpl mutations associated with clinical resistance to dapsone,in Mycobacterium Leprae isolated from South Korea[J].Tropical Medicine & Parasitolngy,2001,95(3):429-432.
7KE Ward,Me Carthy.Depsone-induced methemoglobinemia[J].The annals of pharmacotherapy,1998,32(5):549-553.
8Kumar RH,Kumar MV,Thappa DM.Dapsone syndrome:a five year retrospective analysis[J].Indian journal of leprosy,1998,70(3):271-276.
2[1]Yong VW,Wells J,Giuliani F,et al.The promise oF minocycline in neurology[J].Lancet Neurol,2004,3(12):744-751.
3[2]Wang J,Wei Q,Wang CY,et al.Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria[J].J Biol Chem,2004,279(19):19948-19954.
4[3]Tikka T,Fiebich BL,Goldsteins G,et al.Minocycline,a tetracycline derivative,is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia[J].J Neurosci,2001,21(8):2580-2588.
5[4]Wang X,Zhu S,Drozda M,et al.Minocycline inhibits caspaseindependent and-dependent mitochondrial cell death pathways in models of Huntington's disease[J].Proc Natl Acad Sci USA,2003,100(18):10483-10487.
6[5]Giuliani F,Hader W,Yong VW.Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction[J].Leukoc Biol,2005,78(1):135-143.
7[7]Fulcher D,Wong S.Carboxyfluorescein succinimidyl esterbased proliferative assays for assessment of T cell function in the diagnostic laboratory[J].Immunol Cell Biol,1999,77(6):559-564.
8[8]Clipstone N,Timmermann L,Northrop J,et al.The mechanism of action of cyclosporin A and FK506[J].Clin Immunol Immunopathol,1996,80(3):S40-S45.
9[9]Kloppenburg M,Brinkman BM,De Rooij-Dijk HH,et al.The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes[J].Antimicrob Agents Chemother,1996,40(4):934-940.
